Oil Futures Maintain Positive Bias as Rally Potential Persists Morgan Stanley Lowers Equinor Price Target Following FirstQuarter Results Lenovo Shares Surge Nearly 20 After Record Revenue and AI Revenue Nearly Doubles Traders Now Price Fed Rate Hike as Next Move Following Inflation Surge Diversified Energy Expands Permian Footprint With Maverick Natural Resources Acquisition Elon Musks Critique of The Boys Finale Highlights Crossroads of Entertainment and Political Commentary DAIO Q1 2026 Earnings EPS Misses Estimates Amid Challenging Conditions JBS Q1 2026 Earnings EPS Miss Drags on Stock Despite Resilient Operations CYD Q3 2020 Earnings NearMiss on EPS Stock Gains Despite Slight Disappointment SHIM Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Movement MBRX Q1 2026 Earnings EPS Misses Estimates Widely Stock Rises on Speculative Momentum Angel Studios Inc ANGX Q1 2026 Earnings Narrowing Losses Surprisedriven Stock Rally Black Spade Acquisition III Co BIII Holds Steady at 992 as SPAC Awaits Business Combination Catalyst Korro Bio Inc KRRO Surges 62 as Biotech Stock Tests Key Resistance at 1295 Independent Bank Corporation IBCP Gains 136 as Regional Banking Sector Finds Footing Swarmer Inc SWMR Holds Steady Near Midpoint as Consolidation Persists RF Acquisition Corp III RFAM Holds Steady at 988 Amid Low Volatility China Confirms Order for 200 Boeing Jets Highlighting Aviation as Key Area for US Cooperation Asana Q1 2026 Earnings EPS Beat Drives Modest Stock Gain Smith Nephew SNN Faces Pressure Stock Slips 141 Amid Cautious Market Sentiment CHAI Q4 2025 Earnings Massive EPS Miss as Core AI Holdings Reports Hefty Loss Samsung Strike Suspended as Union Members Vote on Tentative Deal Amid AI Bonus Demands SLMBP Q1 2026 Earnings Preferred Stock EPS Surges 356 Above Estimates Reflecting Strong Core Performance Standard Chartered to Reduce Corporate Functions Roles by Over 15 in Push for Higher Returns SpaceXs Starship Test A Critical Milestone Ahead of Potential IPO TBBB Q1 2026 Earnings Narrowly Misses Estimates Stock Flat Marker Therapeutics Q1 2026 Earnings Loss Narrows as Clinical Progress Continues